Symbol | Exchange | Currency |
|---|
Investors’ interest in financially strong mid-cap companies has been growing because these companies reside in the sweet spot between risky small-cap companies and large-cap...
HLS Therapeutics (OTCPK:HLTRF): Q1 GAAP EPS of -$0.15.Revenue of $14.31M (+3.0% Y/Y) misses by $0.66M.Press Release
Jefferies (NYSE:JEF) analyst Brian Tanquilut reiterated a Buy rating on Encompass Health (NYSE:EHC) on Monday, setting a price target of $100, which is approximately 23.66% above...
PerkinElmer (NYSE:PKI), Inc. PKI reported second-quarter 2021 adjusted earnings per share (EPS) of $2.83, which beat the Zacks Consensus Estimate of $2.41 per share by 17.4%. The...
Encompass Health (NYSE:EHC) Corp. EHC is making concerted efforts to grow its inpatient rehabilitation business. To this end, it recently announced the opening of Encompass Health...
Encompass Health (NYSE:EHC) Corporation EHC has been aided by improving revenues, growing nationwide portfolio and sound liquidity position from operations. A robust outlook for...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Sell | Sell | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,694.50 | 2,706.10 | 2,685.10 | -21.0 | -0.77% | 1.28M | NASDAQ | |||
| 356.30 | 360.73 | 352.94 | -2.02 | -0.56% | 15.98M | NASDAQ | |||
| 53.72 | 53.90 | 53.25 | +0.02 | +0.04% | 16.47M | NASDAQ | |||
| 203.83 | 206.48 | 203.57 | -1.39 | -0.68% | 878.95K | NYSE | |||
| 7.98 | 8.17 | 7.97 | -0.160 | -1.97% | 2.05M | NYSE | |||
| 44.68 | 45.20 | 41.53 | +2.06 | +4.83% | 66.26M | NYSE | |||
| 22.24 | 22.46 | 21.95 | +0.03 | +0.14% | 336.22K | NYSE | |||
| 194.99 | 196.30 | 192.63 | -1.63 | -0.83% | 18.35M | NASDAQ | |||
| 317.68 | 319.18 | 316.90 | -0.67 | -0.21% | 2.31M | NYSE | |||
| 108.58 | 109.85 | 106.40 | +1.68 | +1.57% | 381.52K | NYSE | |||
| 28.05 | 28.40 | 28.01 | -0.24 | -0.85% | 37.50M | NYSE | |||
| 142.23 | 144.54 | 141.55 | +2.75 | +1.97% | 14.39M | NYSE | |||
| 49.31 | 55.29 | 48.59 | -1.25 | -2.47% | 2.36M | NYSE | |||
| 37.02 | 39.19 | 36.79 | -1.11 | -2.91% | 53.00M | NYSE | |||
| 2,704.40 | 2,715.40 | 2,696.30 | -26.4 | -0.97% | 1.20M | NASDAQ |
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment’s hospice services comprise in-home services to terminally ill patients and their families to address patients’ physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of June 14, 2021, it operated 140 hospitals, 250 home health locations, and 93 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.